Title:
【発明の名称】新しい置換環状化合物、これらの製造方法及びこれらを含む薬剤組成物
Document Type and Number:
Japanese Patent JP2002514619
Kind Code:
A
Abstract:
The invention concerns compounds of formula (I): R-A-R' wherein: A is as defined in the description; R represents a group (V), (VI), (VII) or (VIII), where E, Q, R1, R2, R3, v and R4 are as defined in the description; R' represents a -(CH2)t-R5 group wherein t and R5 are as defined in the description.
More Like This:
| WO/2005/073164 | THERAPEUTIC AND CARRIER MOLECULES |
| JPS6045541 | LEUKOTRIENE ANTAGONISTIC SUBSTANCE |
| WO/1999/054283 | POLYAMINE TRANSPORT INHIBITORS |
Inventors:
Le surreal, daniel
Krypsch, Frederick
Guillaume, Gerard
Viau, Marie-Claude
Langlois, Michelle
Benjan, Carolyn
Renard, Pierre
De Lagrange, Philip
Krypsch, Frederick
Guillaume, Gerard
Viau, Marie-Claude
Langlois, Michelle
Benjan, Carolyn
Renard, Pierre
De Lagrange, Philip
Application Number:
JP2000548299A
Publication Date:
May 21, 2002
Filing Date:
May 10, 1999
Export Citation:
Assignee:
Adair e Company
International Classes:
A61K31/16; A61K31/165; A61K31/166; A61K31/17; A61K31/18; A61K31/19; A61K31/27; A61K31/341; A61K31/343; A61K31/352; A61K31/357; A61K31/381; A61K31/382; A61K31/4025; A61K31/403; A61K31/404; A61K31/4045; A61K31/405; A61K31/4184; A61K31/423; A61K31/435; A61K31/4355; A61K31/436; A61K31/4365; A61K31/437; A61K31/4402; A61K31/4427; A61K31/443; A61K31/4433; A61K31/4439; A61K31/4453; A61K31/453; A61K31/454; A61K31/473; A61K31/5355; A61K31/5375; A61K31/5377; A61K31/55; A61P1/00; A61P3/06; A61P3/10; A61P5/02; A61P9/00; A61P15/08; A61P25/00; A61P25/04; A61P25/06; A61P25/08; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P35/00; A61P43/00; C07C233/36; C07C233/40; C07C233/43; C07C233/62; C07C233/65; C07C237/48; C07C271/20; C07C271/30; C07C275/24; C07C275/40; C07C311/46; C07C317/32; C07C323/40; C07C323/41; C07C323/44; C07C323/62; C07D207/27; C07D209/08; C07D209/14; C07D295/12; C07D209/16; C07D209/18; C07D209/20; C07D209/60; C07D209/90; C07D213/70; C07D221/08; C07D221/10; C07D233/42; C07D233/84; C07D235/06; C07D235/14; C07D261/20; C07D295/18; C07D307/68; C07D307/77; C07D307/81; C07D307/92; C07D311/58; C07D311/60; C07D311/92; C07D319/18; C07D319/20; C07D333/20; C07D333/38; C07D333/40; C07D333/50; C07D333/56; C07D333/58; C07D333/74; C07D335/06; C07D335/08; C07D401/12; C07D405/04; C07D405/06; C07D405/12; C07D407/12; C07D409/06; C07D471/04; C07D471/14; C07D491/04; C07D491/048; C07D491/052; C07D493/04; C07D495/04; C07D495/14; C07D521/00; C07D207/26; (IPC1-7): C07C233/40; A61K31/165; A61K31/17; A61K31/19; A61K31/343; A61K31/352; A61K31/357; A61K31/381; A61K31/382; A61K31/4025; A61K31/403; A61K31/404; A61K31/4045; A61K31/405; A61K31/4184; A61K31/423; A61K31/435; A61K31/4365; A61K31/437; A61K31/4402; A61K31/443; A61K31/4433; A61K31/4439; A61K31/4453; A61K31/453; A61K31/473; A61K31/5377; A61K31/55; A61P1/00; A61P9/00; A61P25/00; A61P25/04; A61P25/06; A61P25/08; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P43/00; C07C233/36; C07C317/32; C07C323/40; C07C323/41; C07C323/44; C07D209/08; C07D209/16; C07D209/18; C07D209/60; C07D209/90; C07D213/70; C07D221/10; C07D235/14; C07D261/20; C07D295/12; C07D307/81; C07D311/58; C07D319/18; C07D333/20; C07D333/40; C07D333/50; C07D333/58; C07D333/74; C07D335/06; C07D335/08; C07D401/12; C07D405/04; C07D405/06; C07D405/12; C07D407/12; C07D409/06; C07D471/04; C07D491/052; C07D493/04; C07D495/04
Attorney, Agent or Firm:
Hajime Tsukuni (1 person outside)